View Cart (0 items)

Articles Tagged with ''pharmaceutical industry''

Novo Nordisk locked in legal battle over generic drug

No Comments
Danish pharmaceutical giant Novo Nordisk is being sued by several healthcare purchasing companies that claim the drug maker wrongfully kept generic copies of its diabetes drug Prandin off the market.
Read More

US pharmaceutical spending slightly down from 2012 levels

No Comments
Expenditure on pharmaceuticals in 2013 is predicted to register a minor decline of 0.5% dipping to $341.2 billion from $343 billion in 2012.
Read More

US, European watchdogs join forces to regulate generic drugs

No Comments
The European Medicines Agency and the U.S. Food and Drug Administration have started a joint program for sharing information on bioequivalence studies required during the process of approval for generic drugs.
Read More

FDA tightens grip on Indian drug makers

No Comments
The U.S. Food and Drug Administration (FDA) has warned two Indian pharmaceutical companies over suspected breaches of good manufacturing practices.
Read More

Chinese pharma probe spreads to two Danish drug makers

No Comments
Western pharmaceutical companies are coming under increased scrutiny in China following the bribery accusations leveled last month against GlaxoSmithKline (GSK).
Read More

European biotechs back on venture capital radar

No Comments
Venture capital firms are once again warming to European biotechnology players, which attracted a significant portion of the venture capital invested globally in this sector during the second quarter.
Read More

Generic drug patent settlements cut costs for health systems, study finds

No Comments
The U.S. health system saved a total of $25.5 billion between 2005 and 2012 thanks to generic drugs being launched on the market before patent expirations as a result of patent settlements.
Read More

U.S. pharmaceutical companies granted easier access to EU market

No Comments
The United States is now considered a "listed country" by the European Commission, which means that U.S. companies don’t need an FDA export certificate before shipping certain pharmaceutical products to the European Union.
Read More

AstraZeneca to build new HQ, research center in Cambridge, UK

No Comments
AstraZeneca is investing about £330 million ($515.6 million) in its new building, which will host a global R&D center.
Read More

Bill passed to fight counterfeit drugs

No Comments
The United States has passed a bill intended to set up a national system for tracking pharmaceutical products through the supply chain to prevent counterfeit medicines from accessing the market.
Read More